Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abbott Laboratories
(NY:
ABT
)
102.74
-0.47 (-0.45%)
Streaming Delayed Price
Updated: 12:45 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abbott Laboratories
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday
April 17, 2024
With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead
April 16, 2024
Healthcare stocks disappointed again last week with the XLV down over 3% and up only 1.65 % YTD, in a continued downtrend since March 28.
Via
Talk Markets
3 Buy Rated Stocks To Consider As Earnings Approach
April 13, 2024
With the Q1 earnings season underway, there will be a microscope on companies that can continue to show improvements in their outlook amid an uptick in inflation.
Via
Talk Markets
Jim Cramer Calls Cummins 'Terrific,' Recommends Selling This Chinese Auto Manufacturer
April 12, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes New Fortress Energy Inc.
Via
Benzinga
Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit
April 12, 2024
Continuous glucose monitors have spiked in popularity since the advent of weight-loss drugs. Is chronic disease at its end?
Via
Investor's Business Daily
Abbott Laboratories Dividend Stock Analysis
April 12, 2024
Abbott Laboratories discovers, develops, manufactures, and sells healthcare products. Its products include branded generic pharmaceuticals manufactured internationally, marketed, and sold outside the...
Via
Talk Markets
Abbott Laboratories Unusual Options Activity
April 11, 2024
Via
Benzinga
Analyst Ratings For Abbott Laboratories
April 03, 2024
Via
Benzinga
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
April 11, 2024
These companies provide stability, reliability, and passive income.
Via
The Motley Fool
7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape
April 10, 2024
Although the market may be grumbling over certain issues, concerned investors can trust these healthcare stocks to deliver the goods.
Via
InvestorPlace
Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse'
April 09, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories (NYSE: ABT) over
Via
Benzinga
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
April 09, 2024
Income-seeking investors can look forward to steady payout raises from these pharma stocks.
Via
The Motley Fool
3 Top Dividend Stocks to Buy in April 2024
April 06, 2024
Each of these high-quality stocks looks like a buy.
Via
The Motley Fool
How Is The Market Feeling About Abbott Laboratories?
March 28, 2024
Via
Benzinga
Performance Comparison: Abbott Laboratories And Competitors In Health Care Equipment & Supplies Industry
March 27, 2024
Via
Benzinga
What the Options Market Tells Us About Abbott Laboratories
March 19, 2024
Via
Benzinga
Top Analyst Reports For T-Mobile US, Abbott Laboratories & Palo Alto Networks
April 06, 2024
Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), Abbott Laboratories (ABT) and Palo Alto Networks, Inc. (PANW).
Via
Talk Markets
FDA Approves Abbott's Heart Valve Repair Device For Patients At Risk Of Complications/Death During Open-Heart Surgeries
April 02, 2024
FDA approves Abbott Laboratories' TriClip TEER system for treating tricuspid regurgitation. Clip technology offers non-invasive repair, fast recovery, and significant improvement in quality of life....
Via
Benzinga
Exposures
Product Safety
Russell 2000 Index Best And Worst Performing Stocks Of 2024
April 02, 2024
The Russell 2000 index continued to underperform the Dow Jones and Nasdaq 100 indices in the first quarter of 2024.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
3 Strong Buy Healthcare Stocks to Add to Your Q2 Must-Watch List
March 29, 2024
In an aging world, strong buy healthcare stocks like UNH, ABT, and MRK shine with dividends, innovation, and market growth.
Via
InvestorPlace
$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today
March 08, 2024
Via
Benzinga
Winning Over Wall Street: 3 Stocks Earning Overwhelming Analyst Approval
March 26, 2024
Discover the investment potential of three stocks with analyst approval for their robust financials and strategic market positions.
Via
InvestorPlace
More Than 86% of Analysts Who Cover These 3 Stocks Rate Them a ‘Buy’
March 25, 2024
Investors should take notice of these stocks with high analyst ratings. It's time to load up your portfolio.
Via
InvestorPlace
Want Decades of Passive Income? 2 Stocks to Buy Now.
March 22, 2024
There aren't many guarantees in the equity market, but the dividend payouts of Johnson & Johnson and Abbott Laboratories may be as close as it gets to a sure thing.
Via
The Motley Fool
3 Stocks to Buy Right Now for the Coming Recession
March 21, 2024
With numerous economic indicators souring, these three stocks to buy for a recession will protect your portfolio's downside.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
3 Resilient Stocks to Protect Your Wealth During a Recession
March 21, 2024
Discover three recession-resistant stocks with growth leads in the consumer staples, household products, and healthcare industries.
Via
InvestorPlace
What's Going On With Abbott Laboratories Stock On Friday?
March 15, 2024
An Illinois jury orders Reckitt Benckiser's Mead Johnson to pay $60 million after a premature infant's tragic death linked to Enfamil baby formula. Mead Johnson found negligent for not warning about...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Why Abbott's Formula-Related Sell-Off Could Be A Buying Opportunity, Says Analyst
March 15, 2024
Fellow infant formula maker Reckitt Benckiser was ordered to pay $60 million to a mother whose baby died after eating Enfamil.
Via
Investor's Business Daily
Topics
Death
Exposures
Death
SCHD ETF Spotlight: The Top 6 Stocks Inside This Dividend Monster
March 13, 2024
With over 100 dividend growth stocks in its portfolio, the SCHD ETF has proved to be a formidable income-generating vehicle for investors.
Via
InvestorPlace
Topics
ETFs
3 Dividend Kings of Healthcare Stocks to Buy Hand Over Fist in March
March 11, 2024
These are some of the best-performing stocks in what's arguably society's most important industry.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.